Sunrise Group Secures FDA Clearance for Advanced At-Home Sleep Test, Enhancing Sleep Apnea Diagnosis
Sunrise Group, a leader in medical device innovation and sleep care, has received FDA clearance for its new at-home sleep test device, Sunrise Air. This development marks a significant advancement in the diagnosis of sleep apnea, a condition affecting over 900 million people globally. The Sunrise Air device is designed to be lightweight and ergonomic, featuring a chin-worn sensor that records mandibular jaw movements, a clinically validated biosignal for sleep assessment. The device integrates additional sensors for airflow, oxygen saturation, pulse rate, and snoring analysis, enhancing its ability to detect respiratory events and differentiate between central and obstructive apneas. The device's AI-supported algorithms generate comprehensive sleep reports for clinician review, making it a convenient and reliable alternative to traditional sleep lab tests. 
